Antifungal News and Research

RSS
AstraZeneca signs definitive agreement to acquire Novexel

AstraZeneca signs definitive agreement to acquire Novexel

Pacific Beach BioSciences signs licensing agreement with major pharmaceutical company

Pacific Beach BioSciences signs licensing agreement with major pharmaceutical company

bioMerieux announces the upcoming availability of ABxAlert from ICNet International

bioMerieux announces the upcoming availability of ABxAlert from ICNet International

Researchers attempt to slow the pace of infectious organisms' evolution to keep today's drugs effective

Researchers attempt to slow the pace of infectious organisms' evolution to keep today's drugs effective

New imagining technique may yield better antiviral and anti-cancer drugs

New imagining technique may yield better antiviral and anti-cancer drugs

Report on the global anti-infectives market

Report on the global anti-infectives market

NovaBay Pharmaceuticals' Aganocide compounds demonstrate potent antifungal activity against onychomycosis

NovaBay Pharmaceuticals' Aganocide compounds demonstrate potent antifungal activity against onychomycosis

Mylan Pharmaceuticals and Matrix Laboratories enter into license agreement with Pfizer

Mylan Pharmaceuticals and Matrix Laboratories enter into license agreement with Pfizer

Richmont Sciences to market PURE’s antimicrobial SDC disinfectants

Richmont Sciences to market PURE’s antimicrobial SDC disinfectants

Phase 2 clinical study results of TOPICA's luliconazole for athlete's foot announced

Phase 2 clinical study results of TOPICA's luliconazole for athlete's foot announced

Report on the worldwide market for anti-infectives

Report on the worldwide market for anti-infectives

Phase III results of Lauriad presented at the 49th Annual ICAAC

Phase III results of Lauriad presented at the 49th Annual ICAAC

BioAlliance announces Phase III results of miconazole Lauriad MBT for treatment of oropharyngeal candidiasis

BioAlliance announces Phase III results of miconazole Lauriad MBT for treatment of oropharyngeal candidiasis

U.S. FDA approval of miconazole MBT represents a significant milestone for Strativa Pharmaceuticals

U.S. FDA approval of miconazole MBT represents a significant milestone for Strativa Pharmaceuticals

BioAlliance Pharma's new drug application for oropharyngeal candidiasis treatment accepted by the FDA

BioAlliance Pharma's new drug application for oropharyngeal candidiasis treatment accepted by the FDA

'Nanobee' drug delivery to tumors

'Nanobee' drug delivery to tumors

Tamoxifen kills fungus cells and may prevent them from causing disease

Tamoxifen kills fungus cells and may prevent them from causing disease

Cimzia approved in U.S. for rheumatoid arthritis

Cimzia approved in U.S. for rheumatoid arthritis

Cells get two chances, not just one, to fix their mistakes

Cells get two chances, not just one, to fix their mistakes